Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04975399
Title Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
Local Institution - 104 Birmingham Alabama 35233 United States Details
Local Institution - 105 Scottsdale Arizona 85258 United States Details
Local Institution - 106 Tampa Florida 33612 United States Details
Local Institution - 108 New York New York 10021 United States Details
Local Institution - 107 New York New York 10029 United States Details
Local Institution - 101 Milwaukee Wisconsin 53226 United States Details
Local Institution - 201 Calgary Alberta T2N 4N2 Canada Details
Local Institution - 204 Edmonton Alberta T6G 1Z2 Canada Details
Local Institution - 203 Halifax Nova Scotia B3H 2Y9 Canada Details
Local Institution - 202 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 205 Montreal Quebec H4A3J1 Canada Details
Local Institution - 302 Pamplona Navarra 31008 Spain Details
Local Institution - 301 Badalona 8916 Spain Details
Local Institution - 303 Salamanca 37007 Spain Details
Local Institution - 304 Santander 39008 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field